Prostetrol Modified-release Tablets now in the Egyptian Market January 1, 2011

Prostetrol Modified-release Tablets now in the Egyptian Market

 

 

 

 

 

 

 

 

 

-       Manufactured by Matrix delivery system that achieves optimal pharmacokinetic coverage over 24-hrs.

-        Exhibits high clinical uro-selectivity for prostate over vascular tissue.

-       Rapid onset of action after administration of the first dose

-       No significant changes in blood pressure, even in elderly and hypertensive patients

-       Free from   ejaculatory dysfunction.

-       Convenience of dosing

 -       No need for dose titration

Indications

-       LUTS due to BPH

-       Chronic prostatitis